Evidence map›Paper›PMID 27549369›Full record

ReviewRegenerative medicine2016

The potential impact of bone tissue engineering in the clinic.

Ruchi Mishra, Tyler Bishop, Ian L Valerio, John P Fisher, David Dean

Abstract readReview
In one paragraph

Review in Regenerative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Rational design of hydrogels to enhance osteogenic potential.Chemistry of materials : a publication of the American Chemical Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruchi MishraDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA.
Tyler BishopDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA.
Ian L ValerioDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA.
John P FisherFischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
David DeanDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA.

Funding

STRENGTH AND RESORPTION OF BIODEGRADABLE SKULL IMPLANTSR01DE013740 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI DEAN, DAVID · 2000 to 2011
$4.6M
Application of Tubular Perfusion System (TPS) Generated Prevascularized Bone TissR01AR061460 · NIAMS · UNIV OF MARYLAND, COLLEGE PARK · PI FISHER, JOHN P · 2011 to 2014
$1.3M
NIAMS NIH HHS R01 AR061460NIDCR NIH HHS R01 DE013740
6 · The paper itself

Abstract

Bone tissue engineering (BTE) intends to restore structural support for movement and mineral homeostasis, and assist in hematopoiesis and the protective functions of bone in traumatic, degenerative, cancer, or congenital malformation. While much effort has been put into BTE, very little of this research has been translated to the clinic. In this review, we discuss current regenerative medicine and restorative strategies that utilize tissue engineering approaches to address bone defects within a clinical setting. These approaches involve the primary components of tissue engineering: cells, growth factors and biomaterials discussed briefly in light of their clinical relevance. This review also presents upcoming advanced approaches for BTE applications and suggests a probable workpath for translation from the laboratory to the clinic.

Indexed as

AnimalsBone and BonesBone DiseasesBone RegenerationHumansTissue Engineering3D printingadditive manufacturingbiomaterialsbioreactorbone tissue engineeringcell-based therapy

Identifiers

PMID27549369
PMCPMC5007661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.